Paid Clinical Trials in Billings, MT
As of June 2026, 135 paid clinical trials are recruiting in Billings, Montana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Billings offers studies at sites including Billings Clinic Cancer Center for conditions such as Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Billings
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Billings
Billings has approximately 135 recruiting research studies across a wide range of therapeutic areas. Montana hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Billings
Researchers run research studies in Billings, MT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Billings Clinic Cancer Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 96 |
| Saint Vincent Frontier Cancer Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 21 |
| Saint Vincent Healthcare | Anatomic Stage IV Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia | 12 |
| Intermountain Health West End Clinic | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 8 |
| Billings Clinic | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation, Ovarian Cancer | 3 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana | Melanoma Stage IV, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| St. Vincent Frontier Cancer Center | Chronic Lymphocytic Leukemia, Leukemia, B-cell, Leukemia, Lymphocytic | 2 |
| St. Vincent Frontier Cancer Center-Research ( Site 0037) | Prostatic Neoplasms, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer | 2 |
| Billings Clinic - Billings | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Billings Clinic /ID# 258316 | Hypothyroidism | 1 |
| Billings Clinic Montana Cancer Consortium | Colo-rectal Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Intermountain Health - St. Vincent Frontier Cancer Center | KRAS G12C-mutated Solid Tumors, Lung Cancer, KRAS, NRAS, HRAS-mutated NSCLC, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer | 1 |
| Intermountain Health Saint Vincent Regional Hospital | Cervical Cancer | 1 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0003) | Breast Cancer, Breast Neoplasms | 1 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0052) | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 1 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0178) | Diffuse Large B-Cell Lymphoma | 1 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 2000) | Colon Adenocarcinoma, Rectal Adenocarcinoma | 1 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 253147 | Non Small Cell Lung Cancer | 1 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 260006 | Follicular Lymphoma (FL) | 1 |
| Intermountain Health West End Clinic- Gynecologic Oncology | Cervical Cancer | 1 |
| Intermountain Healthcare | Early Breast Cancer | 1 |
| Massive Bio SYNERGY-AI site | BRCA Gene Rearrangement, Bladder Cancer, Breast Cancer | 1 |
| Montana Cancer Consortium NCORP | Breast Carcinoma, Colorectal Carcinoma, Lung Non-Small Cell Carcinoma | 1 |
Active & Upcoming Studies in Billings (2026)
Recruiting trials in Billings grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (117 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Vaccines (1 active study)
Mental health & behavior (1 active study)
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Billings
- Acute Myeloid Leukemia (6 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Stage IV Lung Cancer AJCC v8 (6 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Stage IVB Prostate Cancer AJCC v8 (6 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Breast Cancer (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Melanoma (5 active studies). Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease.
- Stage IIIB Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Billings
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in Montana are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Montana research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Billings. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Billings
Hipa.ai aggregates every recruiting study in Billings from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Billings?
There are approximately 135 recruiting clinical trials in Billings, Montana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Billings pay participants?
Most recruiting trials in Billings compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Billings?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Billings?
The most common conditions under active study in Billings include Acute Myeloid Leukemia (6), Stage IV Lung Cancer AJCC v8 (6), Stage IVB Prostate Cancer AJCC v8 (6), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Billings?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Billings on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Billings?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Billings?
Recruiting research sites in Billings include Billings Clinic Cancer Center, Saint Vincent Frontier Cancer Center, Saint Vincent Healthcare, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Billings right now?
The largest active categories in Billings are Cancer & tumors (117), Vaccines (1), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.